Effect of continuous positive airway pressure ventilation on serum levels of s100β protein and neuron-specifice enolase in obstructive sleep apnea-hypopnea syndrome patients.
- Author:
Panpan ZHANG
;
Xiaoqing HAN
;
Hongyang WANG
;
Lin LI
;
Ling WANG
;
Min ZHANG
;
Chen LIU
;
Jiangtao YU
- Publication Type:Journal Article
- MeSH:
Continuous Positive Airway Pressure;
Humans;
Phosphopyruvate Hydratase;
blood;
S100 Calcium Binding Protein beta Subunit;
blood;
Sleep Apnea, Obstructive;
blood;
therapy
- From:
Journal of Clinical Otorhinolaryngology Head and Neck Surgery
2015;29(6):509-512
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To explore the effect and clinical significance of serum S100β and NSE on moderate and severe obstructive sleep apnea syndrome (OSAHS) after the continuous positive airway pressure (CPAP).
METHOD:A total of 60 cases with obstructive sleep apnea were choosed with PSG in our hospital in June 2009 to June 2009. According to apnea hypoventilation index and at night the lowest oxygen saturation, divided into severe group (n=60) and moderate group (n=60), selecting 60 cases of healthy physical examination for a control over the same period. According to the length of the course of the disease in patients with each group can be divided into <5 years group, 5-10 years and > 10 years group, severe and moderate groups were recruited to undergo an CPAP treatment,both before and after treatment for 3 months, the lowest oxygen saturation, average blood oxygen saturation and apnea hypoventilation index were determined in moderate and severe groups with PSG, at the same time, serum S100β and NSE were determined with immune enzyme-linked adsorption testing before and after patients in different course of treatment and control group.
RESULT:Compared with pretherapy of severe and moderate groups, the lowest oxygen saturation, average blood oxygen saturation and apnea hypoventilation index were ower after treatment (P<0. 05), serum S100β and NSE in severe and moderate groups before and after treatment were significantly higher than control group (P<0. 05), and two groups > 10 years before and after treatment in patients with serum according to beta and NSE levels higher than 5-10 patients, 5-10 patients before and after treatment according to beta and NSE serum levels higher than <5 years group of patients, the relation between the two groups of patients before and after treatment according to beta and NSE serum levels with the extension of history time increased. Before the treatment serum according to beta and NSE in patients with severe group were higher than moderate group before treatment (P< 0.05). Relation between the two groups after treatment according to beta and serum NSE was significantly decreased the (P<0. 05), the relation between the two groups after treatment according to beta and serum NSE, there was no statistically significant difference (p>0. 05), the relation between two groups according to beta, NSE serum are positively correlated with AHI (P < 0. 01).
CONCLUTION:CPAP significantly reduced serum S100β and NSE levels in patients with OSAHS, both may be important index which evaluated nervous system protection of CPAP in patients with OSAHS.
